Global Pediatric Interventional Cardiology Devices Market Outlook 2016:Catheters, Guidewires

According to WHO (World Health Organization), an estimated 276,000 babies die within 4 weeks of birth every year, from congenital anomalies. In many countries, congenital anomalies are important causes of childhood death, chronic illness and disability. The rising incidences of congenital anomalies, increasing adoption rate, rising awareness raised the need for Pediatric interventional cardiology devices. Recently, with the development of technology, many new types of pediatric interventional cardiology devices, which are more efficient, have been introduced in the market. The rising incidences of congenital anomalies, increasing adoption rate and rising awareness are the key factors that are driving the growth of pediatric interventional cardiology devices market. Furthermore, the large untapped Asia-Pacific market is now rapidly adopting interventional cardiology, which has increased the demand for pediatric interventional cardiology devices. Factors restraining the market growth are high initial setup cost and presence of stringent regulatory environment.
The global pediatric interventional cardiology devices market is segmented on the basis of product type, application and geography. The types of products considered in this report include catheters, guidewires, balloons, stents, vascular closure devices, atherectomy devices and others.

Access Full Report: http://www.intenseresearch.com/market-analysis/world-pediatric-interventional-cardiology-devices-market-opportunities-and.html

Based on applications, the global pediatric interventional cardiology devices market is classified into angioplasty, valvuloplasty, congenital heart defect correction, percutaneous valve replacement, percutaneous valve repair and coronary thrombectomy. Geographically, the report is segmented into four regions, namely, North America, Europe, Asia-Pacific and LAMEA. Few strategies adopted by major market players are collaboration and product launch.

In 2011, Medtronic collaborated with AGA Medicals and recently in 2015, Biotronic announced the launch of its Pantera Pro Coronary Balloon Catheter. The companies profiled in this report are Medtronic Inc., St. Jude Medical, Edward Life Sciences, Terumo Medical, Johnson and Johnson, Biotronic, Boston Scientific, Abbott Vascular, GE Healthcare and Siemens Healthcare.

Request a Brochure of This Report, here: http://bit.ly/2cKtmio

About Intense Research

Intense Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Intense Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651
Email: sales@intenseresearch.com
Web: http://www.intenseresearch.com/

This release was published on openPR.